Showing 261-280 of 753 for: Cochrane Systematic Reviews > Pharmacotherapeutics
- Depot fluspirilene for schizophrenia
Cochrane Systematic Reviews, 3-May-2012
Antipsychotic drugs are the mainstay treatment for schizophrenia and similar psychotic disorders. Long-acting depot injections of drugs such as fluspirilene are extensively used as a means of long-term maintenance treatment.
- Depot haloperidol decanoate for schizophrenia
Cochrane Systematic Reviews, 29-Oct-2008
The mainstay of treatment for schizophrenia is the antipsychotic group of drugs. These are usually given orally but compliance with medication given by this route may be difficult to quantify. Problems with treatment adherence are common. The development
- Depot perphenazine decanoate and enanthate for schizophrenia
Cochrane Systematic Reviews, 4-Aug-2009
Antipsychotic drugs are usually given orally but compliance with medication given by this route may be difficult to quantify. The development of depot injections in the 1960s gave rise to extensive use of depots as a means of long-term maintenance treatme
- Depot pipotiazine palmitate and undecylenate for schizophrenia
Cochrane Systematic Reviews, 4-Aug-2009
Antipsychotic drugs are usually given orally but compliance may be problematic. The development of depot injections in the 1960s gave rise to their extensive use as a means of long-term maintenance treatment. Pipotiazine palmitate is a depot from the phen
- Desmopressin for nocturnal enuresis in children
Cochrane Systematic Reviews, 5-Nov-2008
Enuresis (bed-wetting) is a socially disruptive and stressful condition which affects from 15% to 20% of five year olds, and up to 2% of young adults.
- Diazepam for treating tetanus
Cochrane Systematic Reviews, 14-Sep-2008
Clinical management of the muscle spasms and rigidity of tetanus poses a difficult therapeutic problem to physicians everywhere, especially in resource poor countries. There are wide variations in therapeutic regimens commonly used in clinical practice du
- Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Cochrane Systematic Reviews, 15-Jul-2010
Several dietary factors have been considered to be involved in the increasing incidence of colorectal cancer in industrialised countries. Experimental and epidemiological evidence has been suggestive but not conclusive for a protective role for high dieta
- Dietary supplements for dysmenorrhoea
Cochrane Systematic Reviews, 22-Mar-2016
Dysmenorrhoea refers to painful menstrual cramps and is a common gynaecological complaint. Conventional treatments include non-steroidal anti-inflammatory drugs (NSAIDs) and oral contraceptive pills (OCPs), which both reduce myometrial activity (contracti
- Digitalis for treatment of heart failure in patients in sinus rhythm
Cochrane Systematic Reviews, 18-Mar-2014
Digitalis glycosides have been in clinical use for the treatment of heart failure (HF) for longer than 200 years. In recent years, several trials have been conducted to address concerns about their efficacy and toxicity.
- Dipyridamole for preventing stroke and other vascular events in patients with vascular disease
Cochrane Systematic Reviews, 2-Aug-2010
Patients with limited cerebral ischaemia of arterial origin are at risk of serious vascular events (4% to 11% annually). Aspirin reduces that risk by 13%. In one trial, adding dipyridamole to aspirin was associated with a 22% risk reduction compared with
- Diuretic therapy for newborn infants with posthemorrhagic ventricular dilatation
Cochrane Systematic Reviews, 12-Aug-2008
Intraventricular hemorrhage remains a serious complication of premature birth and post-hemorrhagic hydrocephalus still has no satisfactory treatment. Acetazolamide and furosemide, which both reduce the production of cerebrospinal fluid, have been suggeste
- Diuretics acting on the distal renal tubule for preterm infants with (or developing) chronic lung disease
Cochrane Systematic Reviews, 7-Aug-2011
Lung disease in preterm infants is often complicated with lung edema.
- Diuretics for heart failure
Cochrane Systematic Reviews, 11-Oct-2012
Chronic heart failure is a major cause of morbidity and mortality worldwide. Diuretics are regarded as the first-line treatment for patients with congestive heart failure since they provide symptomatic relief. The effects of diuretics on disease progressi
- Diuretics for Ménière's disease or syndrome
Cochrane Systematic Reviews, 9-Mar-2010
This is an update of a review first published in The Cochrane Library Issue 3, 2006.
- Diuretics for preventing pre-eclampsia
Cochrane Systematic Reviews, 14-Jun-2010
Diuretics are used to reduce blood pressure and oedema in non-pregnant individuals. Formerly, they were used in pregnancy with the aim of preventing or delaying the development of pre-eclampsia. This practice became controversial when concerns were raised
- Diuretics for respiratory distress syndrome in preterm infants
Cochrane Systematic Reviews, 3-Nov-2011
Lung edema may complicate respiratory distress syndrome (RDS) in preterm infants.
- Diuretics for transient tachypnoea of the newborn
Cochrane Systematic Reviews, 20-Nov-2015
Transient tachypnoea of the newborn (TTN) results from delayed clearance of lung liquid and is a common cause of admission of full-term infants to neonatal intensive care units. The condition is particularly common after elective caesarean section. Conven
- Doxapram versus methylxanthine for apnea in preterm infants
Cochrane Systematic Reviews, 25-Feb-2013
Recurrent apnea is common in preterm infants, particularly at very early gestational ages. These episodes of loss of effective breathing can lead to hypoxemia and bradycardia which may be severe enough to require resuscitation including use of positive pr
- Drug treatment for facioscapulohumeral muscular dystrophy
Cochrane Systematic Reviews, 11-Aug-2008
Facioscapulohumeral muscular dystrophy is a progressive muscle disease which has no agreed treatment. Early suggestions that corticosteroids might be helpful were not supported by a subsequent open label study. The beta 2 adrenergic agonist albuterol, als
- Drugs for nocturnal enuresis in children (other than desmopressin and tricyclics)
Cochrane Systematic Reviews, 24-Oct-2012
Enuresis (bedwetting) is a socially stigmatising and stressful condition which affects around 15% to 20% of five-year olds and up to 2% of young adults. Although there is a high rate of spontaneous remission, the social, emotional and psychological costs